Soluble TNF-Like Weak Inducer of Apoptosis as a New Marker in Preeclampsia: A Pilot Clinical Study

Table 2

Comparison of the laboratory data of patients in both groups.

	Patient ()		Control ()
	Mean ± SD	Min–Max	Mean ± SD	Min–Max
Gestational week	33 ± 4	26–39	32 ± 4	26–38	0.13
uPCR (mg/day)	4597 ± 5466	175–15578	180 ± 103	80–612	<0.001
Creatinine (mg/dL)	0.52 ± 0.1	0.4–0.8	0.4 ± 0.1	0.3–0.7	<0.001
Hemoglobin (g/dL)	11.2 ± 1.6	7.8–14.7	11.6 ± 1.2	8.9–13.8	0.27
Platelet (/µL)	234 ± 77	92–404	232 ± 67	89–390	0.91
SGOT (U/L)	30 ± 31	8–188	19 ± 4	10–31	0.06
SGPT (U/L)	18 ± 19	3–98	13 ± 5	6–26	0.17
LDH (IU/L)	253 ± 134	150–846	186 ± 46	129–352	0.01
Uric acid (mg/dL)	4.9 ± 1.2	2.4–7.1	3.2 ± 1.0	1.9–5.9	<0.001
sTWEAK (pg/mL)	332 ± 144	89–686	412 ± 166	142–662	0.04